Pazopanib for the Treatment of Soft Tissue Sarcoma

February 14, 2014
Vicki Keedy, MD

Vicki Keedy, MD, Assistant Professor of Medicine, Clinical Director, Sarcoma Program, Vanderbilt-Ingram Cancer Center, discusses pazopanib for the treatment of soft tissue sarcoma.

Clinical Pearls

Vicki Keedy, MD, Assistant Professor of Medicine, Clinical Director, Sarcoma Program, Vanderbilt-Ingram Cancer Center, discusses pazopanib for the treatment of soft tissue sarcoma.

  • Pazopanib was recently approved for the treatment of patients with advanced soft tissue sarcoma who have received prior chemotherapy
  • Treatment with pazopanib quadrupled progression-free survival compared with placebo
  • Drugs to treat soft tissue sarcoma are generally toxic
  • Pazopanib is well tolerated, with some instances of extended fatigue